Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Celularity
AddedFeb 19, 2024
UpdatedJun 18, 2026
Celularity

Celularity

Public

Celularity, a US-based biotech firm, pioneers in delivering large-scale, quality allogeneic placenta-derived cellular therapies.

HQ
Florham Park, NJ, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Celularity, founded in Florham Park, N.J., is a clinical-stage biotechnology company at the forefront of cellular medicine. The company's core mission is to harness the regenerative power of the postpartum placenta to develop and commercialize advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies. Celularity's vision is to revolutionize treatment for aging-related diseases, degenerative conditions, cancer, and immune disorders through scalable and high-quality therapeutic solutions.

Notable affiliated individuals include Dr. Robert Hariri, a pioneer in the field of cellular medicine. Celularity has attracted significant investment from prominent entities such as Sorrento Therapeutics and United Therapeutics. Key achievements include its listing on NASDAQ under the ticker CELU and the development of a robust pipeline of therapeutic programs. The company's impact lies in its innovative approach to leveraging placental biology to address critical medical needs, potentially transforming the landscape of regenerative medicine.

Celularity - Similar Companies

Platelet BioGenesis logo

Platelet BioGenesis

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cellular Approaches logo

Cellular Approaches

HebeCell logo

HebeCell

hebecellcorp.com

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

ViaCyte logo

ViaCyte

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

Longeveron logo

Longeveron

longeveron.com

Cellino logo

Cellino

cellinobio.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

Cellular Engineering Technologies logo

Cellular Engineering Technologies

celleng-tech.com

ZEO ScientifiX logo

ZEO ScientifiX

organicell.com

Cell Care Therapeutics logo

Cell Care Therapeutics

cell-care.com

Lineage Cell Therapeutics logo

Lineage Cell Therapeutics

lineagecell.com

Celularity - Quick Facts

Who are Celularity's competitors?

Companies similar to Celularity include Platelet BioGenesis, Cell BioEngines, Cellular Approaches and HebeCell.

When was Celularity founded?

Celularity was founded in 2016.

Where is Celularity's headquarters located?

Celularity's headquarters is located in Florham Park, NJ, US.

When was Celularity's last funding round?

Celularity's most recent funding round was for $30M (USD) in May 2022.

How much has Celularity raised to-date?

As of May 26, 2022, Celularity has raised a total of $400M (USD).

How many employees does Celularity have?

Celularity has 225 employees as of Feb 6, 2024.

Celularity - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cell Therapies
Tags
  • Healthtech
Unique IDs
  • ein: 831702591
  • secCik: 0001752828
  • ticker: CELU
  • ticker: CELUW
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research